Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited Price to Sales Ratio (P/S) on February 06, 2025: 13.31

Zota Health Care Limited Price to Sales Ratio (P/S) is 13.31 on February 06, 2025, a 54.35% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Zota Health Care Limited 52-week high Price to Sales Ratio (P/S) is 14.66 on January 17, 2025, which is 10.17% above the current Price to Sales Ratio (P/S).
Zota Health Care Limited 52-week low Price to Sales Ratio (P/S) is 6.26 on June 04, 2024, which is -52.92% below the current Price to Sales Ratio (P/S).
Zota Health Care Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 8.89.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: ZOTA.NS

Zota Health Care Limited

CEO	Dr. Sujit Paul
IPO Date	May 10, 2017
Location	India
Headquarters	Zota House
Employees	445
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Cosmetics Eyewear Personal Care Pharmaceuticals Specialty Retail

Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Key trends

Past 5 years